Diffuse Large B Cell Lymphoma
Showing NaN - NaN of 7
Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Follicular Lymphoma Grade IIIb Trial in Guangzhou (Toripalimab,
Recruiting
- Diffuse Large B Cell Lymphoma
- +5 more
- Toripalimab, Rituximab
- R-CHOP Protocol
-
Guangzhou, Guangdong, ChinaDepartment of hematology department, Nanfang hospital
Apr 6, 2022
Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Follicular Lymphoma Grade IIIb Trial in Guangzhou (Camrelizumab,
Recruiting
- Diffuse Large B Cell Lymphoma
- +5 more
-
Guangzhou, Guangdong, ChinaDepartment of Medical Oncology, Sun Yat-sen University Cancer Ce
Mar 10, 2021
Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in China (CD19-targeted Chimeric Antigen
Recruiting
- Lymphoma, Non-Hodgkin
- +2 more
- CD19-targeted Chimeric Antigen Receptor (CAR) T Cells
-
Beijing, Beijing, China
- +9 more
Jan 17, 2021
Clinical Decision-making in Diffuse Large B-Cell Lymphoma in
Unknown status
- Diffuse Large B Cell Lymphoma
-
Guangzhou, Guangdong, China
- +2 more
Nov 6, 2020
Diffuse Large B Cell Lymphoma, Age Over 80 Years Trial in Guangzhou (lenalidomide combined with rituximab)
Recruiting
- Diffuse Large B Cell Lymphoma
- Age Over 80 Years
- lenalidomide combined with rituximab
-
Guangzhou, Guangdong, ChinaGuangdong provincial people's hospital
Nov 5, 2020
Diffuse Large B Cell Lymphoma Trial in Guangzhou (Lenalidomide)
Not yet recruiting
- Diffuse Large B Cell Lymphoma
-
Guangzhou, Guangdong, ChinaNanfang hospital
Sep 3, 2020
Diffuse Large B Cell Lymphoma Trial in Guangzhou (CHOP combined with CMAB304, CHOP, CMAB304)
Completed
- Diffuse Large B Cell Lymphoma
- CHOP combined with CMAB304
- CHOP, CMAB304
-
Guangzhou, Guangdong, ChinaSUN-YAT-SEN university cancer center
Oct 25, 2011